AI in clinical medicine faces an obstacle no software upgrade can easily fix: the trust of the physicians it is meant to assist.

This is health care’s Uber moment.

Health officials tout effort to develop drugs more quickly, compete with China.

Tech companies including Oura, Samsung seize opportunity, while experts raise concerns.

Healthcare has solved for the hard part. The science, the surgery, the diagnosis: by global standards, we're exceptional. What we haven't solved for is what happens when the patient goes home.

It’s called downcoding. And it’s a trend that has started to reemerge with the advent of AI.

Due 6/23/26! For this online pitch event, R2GConnect will select a group of Pharmacovigilance and Safety Signal Detection teams to pitch directly to pharma partners (AstraZeneca, Sanofi, Pfizer, and others) on June 30.

AI-native B2B buyers finish their evaluation before your sales rep says hello. The funnel is now fiction. Here’s what winning companies do instead.

For this online pitch event, R2GConnect will select a group of Pharmacovigilance and Safety Signal Detection teams to pitch directly to pharma partners (AstraZeneca, Sanofi, Pfizer, and others) on June 30.

AI is becoming agentic, from responding to prompts to acting and coordinating on your behalf. I believe this evolution will not just be the defining transformation of the year, but of the next decade.

Artificial intelligence companies are quietly consuming your company’s most valuable asset. Here’s what some leaders are doing about it. 

This monthly segment offers practical strategies for building generational wealth, safeguarding family assets, and navigating financial challenges in underserved communities.

Donna R. Cryer argues healthcare is deploying AI without meaningful patient representation in governance.

The United States hasn’t built a healthcare system designed to lower costs. Instead, it has built an industry dedicated to arguing over them. 

Will doctors or patients who are burned by one AI solution trust the next one they’re given?

A new WTW survey found that employers are rapidly adopting AI in health benefits despite concerns about governance, resources, privacy and compliance.

We are all more productive, but are we still thinking?

The Department of Health and Human Services is moving from “pay and chase” to real-time AI screening across Medicare, Medicaid, CHIP and the Marketplace.

Every investor I've spoken with over the last few months has said some version of the same thing: "We're waiting for the IPOs.” They mean SpaceX. OpenAI. Anthropic. Three companies heading public this year with a combined paper valuation approaching $3 trillion.

My patients don’t wait for me anymore. That’s not a complaint. It’s a clinical reality I had to sit with before I could do anything useful about it.